• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病中的人类白细胞抗原

HLA antigens in Kawasaki disease.

作者信息

Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, Kawasaki T

出版信息

Pediatrics. 1978 Feb;61(2):252-5.

PMID:634680
Abstract

Two hundred five patients with Kawasaki disease and 500 normal controls were HLA-typed, using a standard microcytotoxicity test of tissue typing. HLA-BW22 was more common in patients with Kawasaki disease than in normal controls (25.4% instead of 11.8%, corrected P less than .0005). Among subtypes of HLA-BW22 antigen, Kawasaki disease was associated with HLA-BW22J2, which was found specifically in Japanese and not in Caucasians. These facts may suggest that there is a gene controlling the susceptibility to Kawasaki disease and linked with a Japanese-specific HLA antigen.

摘要

采用标准的组织分型微量细胞毒性试验,对205例川崎病患者和500名正常对照者进行了HLA分型。HLA - BW22在川崎病患者中比在正常对照者中更为常见(分别为25.4%和11.8%,校正P值小于0.0005)。在HLA - BW22抗原的亚型中,川崎病与HLA - BW22J2相关,后者仅在日本人中发现,而在白种人中未发现。这些事实可能提示存在一个控制川崎病易感性并与日本特异性HLA抗原连锁的基因。

相似文献

1
HLA antigens in Kawasaki disease.川崎病中的人类白细胞抗原
Pediatrics. 1978 Feb;61(2):252-5.
2
HLA antigens in mucocutaneous lymph node syndrome in New England.新英格兰地区黏膜皮肤淋巴结综合征中的人类白细胞抗原
Pediatrics. 1981 May;67(5):741-3.
3
Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome.
Hum Immunol. 1983 Feb;6(2):75-7. doi: 10.1016/0198-8859(83)90063-0.
4
HLA antigens in mucocutaneous lymph node syndrome.黏膜皮肤淋巴结综合征中的人类白细胞抗原
Am J Dis Child. 1977 Dec;131(12):1417-8. doi: 10.1001/archpedi.1977.02120250099033.
5
HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients.
Tissue Antigens. 1982 Aug;20(2):144-6. doi: 10.1111/j.1399-0039.1982.tb00337.x.
6
[Progress in the studies on Kawasaki disease].[川崎病的研究进展]
Nihon Rinsho. 1983;41(1):180-90.
7
[In vitro Lymphocyte response to mite antigen in Kawasaki disease (MCLS)].[川崎病(MCLS)中淋巴细胞对螨抗原的体外反应]
Arerugi. 1982 Oct;31(10):1070-3.
8
Kawasaki disease: association with uveitis in seven patients.
Pediatrics. 1982 Mar;69(3):376-8.
9
Is Kawasaki HLA associated?川崎病与人类白细胞抗原有关联吗?
Prog Clin Biol Res. 1987;250:475-84.
10
Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination.
Arthritis Rheum. 1985 Aug;28(8):938-40. doi: 10.1002/art.1780280814.

引用本文的文献

1
Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease.内皮功能障碍:川崎病的分子机制与治疗策略
Int J Mol Sci. 2024 Dec 12;25(24):13322. doi: 10.3390/ijms252413322.
2
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs:诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
3
A systematic review and meta-analysis of the epidemiological characteristics of COVID-19 in children.
一项关于儿童 COVID-19 流行病学特征的系统评价和荟萃分析。
BMC Pediatr. 2022 Oct 22;22(1):613. doi: 10.1186/s12887-022-03624-4.
4
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.儿童多系统炎症综合征与川崎病:关键对比。
Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.
5
Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.川崎病的免疫发病机制及免疫治疗前景
Front Pediatr. 2021 Jul 19;9:697632. doi: 10.3389/fped.2021.697632. eCollection 2021.
6
Epigenetics in Kawasaki Disease.川崎病中的表观遗传学
Front Pediatr. 2021 Jun 25;9:673294. doi: 10.3389/fped.2021.673294. eCollection 2021.
7
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.川崎病与儿童新型冠状病毒病相关的多系统炎症综合征之间的表型、易感性、自身免疫和免疫治疗。
Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.
8
Leveraging Genetic Findings for Precision Medicine in Vasculitis.利用遗传学研究成果推进血管炎精准医疗
Front Immunol. 2019 Aug 2;10:1796. doi: 10.3389/fimmu.2019.01796. eCollection 2019.
9
Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.川崎病的生物标志物:临床应用及面临的挑战
Front Pediatr. 2019 Jun 18;7:242. doi: 10.3389/fped.2019.00242. eCollection 2019.
10
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.全基因组关联分析鉴定出 NMNAT2 和 HCP5 是川崎病的易感基因位点。
J Hum Genet. 2017 Dec;62(12):1023-1029. doi: 10.1038/jhg.2017.87. Epub 2017 Aug 31.